TITAN MEDICAL INC (TMDI)

CA88830X8199 - Common Stock

0.14  -0.05 (-26.32%)

After market: 0.1241 -0.02 (-11.36%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to TMDI. TMDI was compared to 195 industry peers in the Health Care Equipment & Supplies industry. TMDI has a bad profitability rating. Also its financial health evaluation is rather negative. TMDI is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

TMDI had negative earnings in the past year.
In the past year TMDI has reported a negative cash flow from operations.
In the past 5 years TMDI always reported negative net income.
In the past 5 years TMDI always reported negative operating cash flow.

1.2 Ratios

The profitability ratios for TMDI are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TMDI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

TMDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TMDI has been increased compared to 1 year ago.
TMDI has a better debt/assets ratio than last year.

2.2 Solvency

TMDI has an Altman-Z score of -26.47. This is a bad value and indicates that TMDI is not financially healthy and even has some risk of bankruptcy.
TMDI has a Altman-Z score of -26.47. This is amonst the worse of the industry: TMDI underperforms 89.67% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that TMDI is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.17, TMDI perfoms like the industry average, outperforming 51.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -26.47
ROIC/WACCN/A
WACC8.45%

2.3 Liquidity

A Current Ratio of 1.41 indicates that TMDI should not have too much problems paying its short term obligations.
TMDI has a worse Current ratio (1.41) than 82.63% of its industry peers.
A Quick Ratio of 1.41 indicates that TMDI should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.41, TMDI is not doing good in the industry: 69.01% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.21% over the past year.
The Revenue for TMDI has decreased by -50.23% in the past year. This is quite bad
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-20.64%
Revenue 1Y (TTM)-50.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

TMDI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TMDI!.
Industry RankSector Rank
Dividend Yield N/A

TITAN MEDICAL INC

NASDAQ:TMDI (3/9/2023, 7:00:01 PM)

After market: 0.1241 -0.02 (-11.36%)

0.14

-0.05 (-26.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-50.23%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y